RxDoctor Payments Data

Beata Casanas, MD

Infectious Disease · Tampa, FLNPI 1467408591

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $146,865 of the $227,251 with a category attached, or 64.6%. Viiv Healthcare Company accounts for 74.9% of it on its own, with 6 other manufacturers making up the rest. Among infectious disease clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$227,251in general payments, 2019–2025

Across 244 payments — averaging $931.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Viiv Healthcare Company$170K
  • AbbVie$40K
  • Insmed, Inc.$15K
  • Theratechnologies Inc.$2K
  • Merck$108
  • Gilead$48
  • plus $22 from 1 others
$365,395in research payments, 2019–2025

Across 180 payments — averaging $2029.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Insmed, Inc.$269K
  • Viiv Healthcare Company$96K

What the payments were for

  • Consulting fees$57,26325%
  • Speaking & faculty fees$146,86565%
  • Travel & lodging$16,9197%
  • Food & beverage$6,1863%
  • Education$180%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Viiv Healthcare Company165$170,125
AbbVie(2 entities)50$39,594
Insmed, Inc.20$15,353
Theratechnologies Inc.2$2,000
Merck3$108
Gilead3$48
Melinta Therapeutics, LLC1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$227,251 in reported general payments places this provider in the 95th percentile of 669 infectious disease providers in Florida.

See all infectious disease providers in Florida

Medicare billing

Part B allowed, 2024
$4,728
Medicare patients
31
Services billed
57

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →